Results 11 to 20 of about 7,309,579 (256)

Cardiovascular risk factors, global cardiovascular risk, and vascular age in a cohort of Peruvian HIV patients

open access: yesHIV & AIDS Review. International Journal of HIV-Related Problems
Introduction Data on cardiovascular risk and vascular age in patients with human immunodeficiency virus (HIV) from developing countries are scarce. Therefore, the current study aimed to determine the prevalence of cardiovascular risk factors, global ...
German Valenzuela-Rodriguez   +5 more
doaj   +2 more sources

SCORE2-diabetes : 10-year cardiovascular risk estimation in type 2 diabetes in Europe [PDF]

open access: yes, 2023
Aims: To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease (CVD) in individuals with type 2 diabetes in Europe.Methods and results: SCORE2-Diabetes was developed by extending ...
Azzopardi, Joseph   +3 more
core   +2 more sources

Neighborhoods and Cardiovascular Risk: Beyond Individual-Level Risk Factors

open access: yes, 2008
Efforts to prevent and treat cardiovascular disease have traditionally focused on individual-level risk factors. However, recent work has highlighted the role of residential environments in shaping the distribution of cardiovascular outcomes and risk ...
Diez Roux, Ana V., Lisabeth, Lynda D.
core   +7 more sources

Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data. [PDF]

open access: yes, 2011
To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events and mortality in patients using diabetes medication. The General Practice Research Database was used to identify inception cohorts of insulin and different
Van Staa, Tjeerd; id_orcid   +19 more
core   +6 more sources

Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome

open access: yesRMD Open, 2023
Background To examine blood pressure (BP) and lipid treatment eligibility in antiphospholipid syndrome (APS) according to European Alliance of Associations for Rheumatology (EULAR) and European Society of Cardiology (ESC) recommendations.Methods ...
Maria G Tektonidou   +3 more
doaj   +1 more source

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction [PDF]

open access: yes, 2012
BACKGROUND: There is debate about the value of assessing levels of C-reactive protein (CRP) and other biomarkers of inflammation for the prediction of first cardiovascular events.
Iso, Hiroyasu   +440 more
core   +3 more sources

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies [PDF]

open access: yes, 2011
BACKGROUND: Guidelines differ about the value of assessment of adiposity measures for cardiovascular disease risk prediction when information is available for other risk factors. We studied the separate and combined associations of body-mass index (BMI),
Nordestgaard, Borge G.   +77 more
core   +1 more source

Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty

open access: yesMedicina, 2021
A 78-year-old man came to our attention after undergoing coronary computed tomography angiography documenting multivessel coronary artery disease. He was started on treatment with the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor ...
Federica Fogacci   +3 more
doaj   +1 more source

C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease [PDF]

open access: yes, 2003
C-reactive protein (CRP) has been proposed as a risk factor for cardiovascular disease; however, this association is confounded by mutual relationships with both classical and haematological cardiovascular risk factors. We, therefore, measured CRP with a
Lowe, G.D.O.   +3 more
core   +1 more source

Circulating linoleic acid at the time of myocardial infarction and risk of primary ventricular fibrillation

open access: yesScientific Reports, 2022
Primary ventricular fibrillation (PVF) is a major driver of cardiac arrest in the acute phase of ST-segment elevation myocardial infarction (STEMI). Enrichment of cardiomyocyte plasma membranes with dietary polyunsaturated fatty acids (PUFA) reduces ...
Teresa Oliveras   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy